Looking for volunteers
Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors
NCT07588932 · Spaulding Rehabilitation Hospital · Updated 14 July 2026
- What is being tested
- Telmisartan, Metformin, Cilostazol
- For
- Stroke
- Kind of study
- Tests a treatment or device on volunteers. Early phase 1.
- Who can join
- Ages 21 years to 80 years. About 50 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 18 May 2026, ends 31 Dec 2028. Registered 15 May 2026.
- Results
- None posted yet.
In the researchers' words
The goal of this trial is to study if the concomitant administration of Telmisartan, Cilostazol IR (immediate release), and Metformin ER (extended release) can help stroke survivors make greater gains in movement and recovery during robot-assisted arm and hand rehabilitation.
Sites
- Spaulding Rehabilitation HospitalCharlestown, Massachusetts, United States